Mangoceuticals (MGRX) Amortization - Intangibles (2025 - 2026)
Mangoceuticals (MGRX) reported Amortization - Intangibles of $276815.0 for Q1 2026, little changed on a YoY basis from $276815.0 in Q1 2025, and little changed sequentially from $276815.0 in Q1 2025.
Mangoceuticals (MGRX) Amortization - Intangibles (2025 - 2026) Analysis & Trends
Mangoceuticals (MGRX) has 2 years of Amortization - Intangibles data on file, last reported at $276815.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 31.74 Bn | 24.42 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.64 Bn | 13.74 Bn | 482.22 Mn |
| 3 | Healthequity | 8.32 Bn | 8.05 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.83 Bn | 5.29 Bn | 106.18 Mn |
| 6 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn |
| 7 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn |
| 8 | Doximity | 3.94 Bn | 3.20 Bn | 125.97 Mn |
| 9 | Privia Health | 3.18 Bn | 2.76 Bn | - |
| 10 | Mangoceuticals | 8.68 Mn | 8.49 Mn | 29,001.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 276,815.00 |
| Mar 31, 2025 | 276,815.00 |